Nurses Can Help Mitigate Prostate Cancer Disparities
Disparities exist across many cancer types, but they are particularly prevalent in patients with prostate cancer, explained Maggie A. Smith, DNP, MSN/Ed, RN, OCN, field medical director in GU Oncology at Pfizer, and Oncology Nursing News contributor.
African American men have some of the highest incidences and mortality rates from prostate cancer. To address this, oncology nurses can push for more inclusion in clinical trials, and educate their African American patients on the disease and prevention.
FDA Launches Priority Review of Enfortumab Vedotin Plus Pembrolizumab in Advanced Urothelial Cancer
December 4th 2023The FDA has granted enfortumab vedotin plus pembrolizumab priority review status for patients with locally advanced or metastatic urothelial cancer following data from the phase 3 EV-302/KEYNOTE-A39 trial.
Patients With Prostate Cancer Report Better Quality of Life With 18 Months of ADT vs 36 Months
November 23rd 2023Patients with prostate cancer who received 18 months of androgen deprivation therapy were more likely to recover their serum testosterone levels and to recover quicker than those who received 36 months of therapy.
